Saturday, October 31, 2026

USD/EUR Slides By 1% In The Last 10 Sessions

ViaNews Editorial Team

September 24, 2024

USD/EUR Slides By 1% In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.39% for the last 10 sessions. At 16:10 EST on Tuesday, 24 September, USD/EUR (USDEUR) is $0.89.

USD/EUR's yearly highs and lows, it's 0.19% up from its 52-week low and 6.531% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.02%, a negative 0.03%, and a positive 0.26%, respectively.

USD/EUR's highest amplitude of average volatility was 0.19% (last week), 0.27% (last month), and 0.26% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • According to FXStreet on Monday, 23 September, "This is not a great environment for the Euro, nor for EUR/USD to push above major resistance at 1.12. ", "Further EUR/USD consolidation in a 1.11-1.12 range seems likely, ING's FX strategist Chirs Turner notes."
  • Eur/usd eases back after misfire in EU PMI figures. According to FXStreet on Monday, 23 September, "Tuesday will be a quiet affair on the EUR/USD front; little data is expected from either side of the Atlantic, though Federal Reserve (Fed) Governor Michelle Bowman is expected to make an appearance.", "Despite intraday weakness, EUR/USD continues to remain overall well-bid, with the pair testing into yearly highs despite an inability to reclaim the 1.1200 handle."
  • According to FXStreet on Tuesday, 24 September, "Were it not for the global inflationary environment EUR/USD would look more vulnerable under 1.1100. ", "For the time being, however, we slightly favour this 1.1100-1.1150 range to hold, with the best news for EUR/USD potentially coming with US price data on Friday."
  • According to FXStreet on Tuesday, 24 September, "Even if not much remained of yesterday's EUR-negative shock in the end, the market reaction reminds us that our expectation of rising EUR/USD rates is also based on the euro areanotsliding into a recession. ", "If the situation were to deteriorate significantly, our EUR/USD forecast would be at risk."

More news about USD/EUR (USDEUR).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com